Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Akorn, Inc. Announces Fourth Quarter 2012 Earnings Release And Conference Call Information

Akorn, Inc. Announces Fourth Quarter 2012 Earnings Release And Conference Call Information

LAKE FOREST, Ill., Feb. 5, 2013 /PRNewswire/ -- Akorn, Inc. (NASDAQ: AKRX) will host a conference call on Tuesday, February 26, 2013, to discuss fourth quarter and year-end 2012 results followed by a Q&A session.  The company will release earnings the same day before the market opens.

Subject:

Akorn, Inc. Fourth Quarter 2012 Conference Call

Date/Time:

Tuesday, February 26, 2013, at 10:00 a.m. Eastern Time

Domestic Callers:

888-438-5448

International Callers:

719-785-1753

Confirmation Code:

3343969

URL For Webcast:

http://www.videonewswire.com/event.asp?id=92105

A live broadcast of Akorn's conference call will also be available online at www.akorn.com under the Investor Relations tab on February 26, 2013, beginning at 10:00 a.m. (Eastern Time).  The online replay will follow immediately and will be available for 30 days. 

About Akorn, Inc.

Akorn, Inc. is a niche pharmaceutical company engaged in the development, manufacture and marketing of multisource and branded pharmaceuticals.  Akorn has manufacturing facilities located in Decatur, Illinois; Somerset, New Jersey and Paonta Sahib, India where the Company manufactures sterile ophthalmic and injectable pharmaceuticals.  Additional information is available on the Company's website at www.akorn.com.

SOURCE Akorn, Inc.